Transesophageal and transthoracic echocardiography and Doppler-examinations in systemic lupus erythematosus

References

• Bulkley BH, Roberts WC. The heart in systemic lupus eryth-ematosus and the changes induced in it by corticosteroid therapy. Am J Med 1975;58:243–64.
   PubMed Web of Science ®Google Scholar
• Petri M, Lakatta C, Magder L, Goldman D. Effect of prednis-one and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis. Am J Med 1996;96:254–9.
   Google Scholar
• Jonsson H, Nived O, Sturfelt G. Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population. Medicine 1989;68: 141–50.
   Google Scholar
• Leung WH, Wong KL, Lau CP, Wong CK, Liu HW. Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus. Am J Med 1990;89:411–9.
   Google Scholar
• Crozier IG, Li E, Milne MJ, Nicholls MG. Cardiac involve-ment in systemic lupus erythematosus detected by echocardiog-raphy. Am J Cardiol 1990;65:1145–8.
   PubMed Web of Science ®Google Scholar
• Nihoyannopoulos P, Gomez PM, Joshi J, Loizou S, Walport MJ, Oakley CM. Cardiac abnormalities in systemic lupus erythematosus. Circulation 1990;82:369–75.
   PubMedGoogle Scholar
• Cervera R, Font J, Pare C, et al. Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients. Ann Rheum Dis 1992;51:156–9.
   PubMed Web of Science ®Google Scholar
• Sturfelt G, Eskilsson J, Nived O, Truedsson L, Valind S. Cardiovascular disease in systemic lupus erythematosus. Medicine 1992;71:216–23.
   Google Scholar
• Gleason CB, Stoddard MF, Wagner SG, Longaker RA, Pierangeli S, Harris EN. A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome versus anticardiolipin-negative systemic lupus erythematosus. Am Heart J 1993;125: 1123–9.
   PubMed Web of Science ®Google Scholar
• Hart RG. Cardiogenic embolism to the brain. Lancet 1992;339:589–94.
   PubMedGoogle Scholar
• Roldan CA, Shively BK, Lau CC, Gurule FT, Smith EA, Crawford MH. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphos-pholipid antibodies. J Am Coll Cardiol 1992;20:127–34.
   PubMedGoogle Scholar
• Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 1996;335:1424–30.
   Google Scholar
• Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271–7.
   PubMed Web of Science ®Google Scholar
• Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072–83.
   PubMed Web of Science ®Google Scholar
• Appleton CP, Hatle LK, Popp RL. Superior vena cava and hepatic vein Doppler echocardiography in healthy adults. J Am Coll Cardiol 1987;10:1032–9.
   PubMed Web of Science ®Google Scholar
• Helmcke F, Nanda NC, Hsiung MC, et al. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 1987;75:175–83.
   PubMed Web of Science ®Google Scholar
• Perry GJ, Helmcke F, Nanda NS, et al. Evaluation of aortic insufficiency by color Doppler flow mapping. J Am Coll Cardiol 1987;9:952–9.
   PubMed Web of Science ®Google Scholar
• Seward JB, Khandheria BK, Oh JK, et al. Transesophageal echocardiography: technique, anatomic correlations, imple-mentation, and clinical applications. Mayo Clin Proc 1988;63:649–80.
   PubMed Web of Science ®Google Scholar
• Meijburg HW, Visser CA, Bredee JJ, Westerhof PW. Clinical relevance of Doppler pulmonary venous flow characteristics in constrictive pericarditis. Eur Heart J 1995;16:506–13.
   PubMedGoogle Scholar
• Yoshida K, Yoshhikawa J, Shakudo M, et al. Color Doppler evaluation of valvular regurgitation in normal subjects. Circulation 1988;78:840–7.
   PubMed Web of Science ®Google Scholar
• Bombardieri C, Gladman DD, Urowitz MB, Caron D, Chang CH, and the Committee on Prognosis Studies in SLE: Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630–40.
   PubMedGoogle Scholar
• Horowitz MS, Rossen R, Harrison DC. Echocardiographic diagnosis of pericardial disease. Am Heart J 1979;97:420–7.
   Google Scholar
• Taams MA, Gussenhoven EJ, Cahalan MK, et al. Transesophageal Doppler color flow imaging in the detection of native and Björk-Shiley mitral valve regurgitation. J Am Coll Cardiol 1989;13:95–9.
   PubMedGoogle Scholar
• Ong ML, Veerapen K, Chambers JB, Lim MN, Manivasagar M, Wang F. Cardiac abnormalities in systemic lupus eryth-ematosus: prevalence and relationship to disease activity. Int J Cardiol 1992;34:69–74.
   PubMedGoogle Scholar
• Gabrielli F, Alcini E, Di-Prima MA, Mazzacurati G, Masala C. Cardiac valve involvement in systemic lupus erythema-tosus and primary antiphospholipid syndrome: lack of corr-elation with antiphospholipid antibodies. Int .1- Cardiol 1995;51: 117–26.
   Google Scholar
• Jacobsen S, Petersen J, Ullman S, et al. Mortality and causes of death of 513 Danish patients with systemic lupus eryth-ematous. Scand J Rheumatol 1999;28:75–80.
   PubMed Web of Science ®Google Scholar
• Giunta A, Picillo U, Maione S, et al. Spectrum of cardiac involvement in systemic lupus erythematosus: echocardio-graphic, echo-Doppler observations and immunological investigation. Acta Cardiol 1993;48:183–97.
   PubMedGoogle Scholar
• Moroni G, La Marchesina U, Banfi G, Maccario M, Ponticelli C. Cardiac involvement in long-term lupus nephritis (abstract). Lupus 1995;4:175.
   Google Scholar